The Optical Biopsy Blog - Mauna Kea Technologies' Official Corporate Blog

New CE Mark for Minimally-Invasive Surgery Applications for Cellvizio

Posted by Sacha Loiseau

August 27, 2015 at 12:06 PM

This summer we entered exciting new territory at Mauna Kea Technologies, integrating Cellvizio imaging technology with OR suites in the minimally invasive surgery market. And now we have a new CE mark that will allow us to support more surgeons with immediate actionable information that can be used to optimize interventions.

Read More

Topics: Mauna Kea Technologies, Company news, Endomicroscopy, Surgery

Building Consensus as the International Community of Cellvizio Users Expands

Posted by Sacha Loiseau, Ph.D., President and CEO

June 25, 2014 at 10:44 AM

In any discipline, and particularly in the field of medicine, change takes time. Advanced technology that disrupts the traditional way of doing things requires early adopters who see value and are eager to share the potential with their peers. As technology becomes more accessible, a large community is formed that carries significant weight in advocacy and in practice. That is the case for Cellvizio and the future of Optical Biopsy.

Read More

Topics: Mauna Kea Technologies, Company news, Optical Biopsy

Commitment to Communication: Introducing the Mauna Kea Corporate Blog

Posted by Sacha Loiseau, Ph.D., President and CEO

April 29, 2014 at 11:47 AM

In a world where communication about health, technology, and business is taking place on platforms for real-time conversations with many different audiences, at Mauna Kea Technologies we have decided it’s time to take an important new step in our ongoing commitment to keeping you informed about our progress in delivering the benefits of Cellvizio to patients and clinicians around the world. This new blog is an opportunity for us to provide perspectives on our business strategy and progress.

In the coming months we’ll provide updates on clinical research and publications that support our mission to position optical biopsy as the standard of care in multiple therapeutic areas and indications in the years ahead. We’ll share many of the compelling case studies that show how cutting-edge imaging technology is bringing the smallest microscope in the world to the patient, with critical benefits including real-time evaluation of tissue with immediate diagnostic results to support faster and more effective intervention. We’ll also post content developed by clinicians from around the world who share their perspectives with us, and we’ll give you additional insights about our news to show how important developments fuel our growth.

Read More

Topics: Mauna Kea Technologies, Company news, Optical Biopsy

     

About this blog

The latest news and information about Mauna Kea Technologies and Cellvizio Optical Biopsy, the Fastest Way to See Cancer. 

Subscribe to Email Updates